Literature DB >> 8386873

Persistent infection of human erythroblastoid cells by poliovirus.

R E Lloyd1, M Bovee.   

Abstract

Human erythroblastoid K562 cells have been recently described as a relatively nonpermissive host for poliovirus replication. During investigations of virus-induced cytopathic effects in this cell line, we discovered that poliovirus easily established persistently infected cultures in K562-Mu cells. In these cultures, most cells remained viable, with overall viability continuously maintained between 67 and 92% over 3 months. Infected K562 cells continued to grow, usually without any major periods of crisis in the culture or large diminutions in cell growth rate. K562-Mu cells produced a slower onset of virus production than observed in HeLa cells, and virus titers in culture supernates rapidly stabilized at levels between 10(5) and 10(6) PFU/ml. In infectious center or limiting dilution assays, only about 10% of K562 cells produced infectious virus after 2 days. However, when assays were extended to 3 to 5 days, most K562 cells in the culture scored as infectious centers, suggesting productive infection of all cells in the culture with delayed kinetics of virus production. Cultures of infected K562 cells could not be cured of virus by prolonged incubation with high-titer neutralizing antibody. Pulse-label SDS-PAGE analysis of infected cultures detected moderate levels of virus protein synthesis which peaked at 9-12 hr postinfection; however, little or no shutoff of host protein synthesis was observed at any time point during infection. Immunoblot analysis with antisera to the p220 subunit of eIF-4F demonstrated extensive but incomplete cleavage of p220 in infected K562 cells at times which correlated with peak viral protein synthesis. Taken together, the results demonstrate a persistent infection in which host cell shutoff does not occur despite significant viral protein synthesis and extensive early degradation of p220.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386873     DOI: 10.1006/viro.1993.1250

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Nonlytic viral spread enhanced by autophagy components.

Authors:  Sara Whitney Bird; Nathaniel D Maynard; Markus W Covert; Karla Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Role of microtubules in extracellular release of poliovirus.

Authors:  Matthew P Taylor; Trever B Burgon; Karla Kirkegaard; William T Jackson
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

3.  Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis.

Authors:  Trever B Burgon; Jomaquai A Jenkins; Stephen B Deitz; Jeannie F Spagnolo; Karla Kirkegaard
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

4.  Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.

Authors:  S F Yu; P Benton; M Bovee; J Sessions; R E Lloyd
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

Review 5.  Escape of non-enveloped virus from intact cells.

Authors:  Sara W Bird; Karla Kirkegaard
Journal:  Virology       Date:  2015-04-15       Impact factor: 3.616

6.  Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.

Authors:  M J Bouchard; D H Lam; V R Racaniello
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.

Authors:  I Ventoso; L Carrasco
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication.

Authors:  M E Morrison; Y J He; M W Wien; J M Hogle; V R Racaniello
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro.

Authors:  M Joachims; P C Van Breugel; R E Lloyd
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 10.  Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death.

Authors:  Katharine G Harris; Carolyn B Coyne
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-15       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.